Advertisement

Senate committee advances Trump pick to lead FDA and other late news

By Modern Healthcare  |  April 29, 2017

A Senate committee last week voted to send the nomination of Dr. Scott Gottlieb as head of the Food and Drug Administration​ to the full Senate. Members of the Senate Health, Education, Labor and Pensions Committee voted 14-9 to advance Gottlieb's nomination as FDA...

Gottlieb gets committee approval to lead FDA

By Maria Castellucci  |  April 27, 2017

A Senate committee voted 14-9 to send Dr. Scott Gottlieb's nomination as head of the U.S. Food and Drug Administration to the full Senate.

St. Jude Medical concealed defects in devices, FDA says

St. Jude Medical concealed defects in devices, FDA says

By Maria Castellucci  |  April 14, 2017

St. Jude Medical, which is now part of Abbott Laboratories, failed to appropriately correct issues found in some of its cardiovascular devices, according to the U.S. Food and Drug Administration.

Editorial: Which Scott Gottlieb will run the FDA?

Editorial: Which Scott Gottlieb will run the FDA?

By Merrill Goozner  |  April 08, 2017

Dr. Scott Gottlieb is by far the most conflicted person nominated to run the 111-year-old Food and Drug Administration. If the Office of Government Ethics was doing its job, it wouldn't let him near the commissioner's chair for at least a year.

Senate panel to discuss future of FDA user fees

Senate panel to discuss future of FDA user fees

By Adam Rubenfire  |  April 01, 2017

The U.S. Senate Health, Education, Labor & Pensions Committee will evaluate the future of the fees the Food and Drug Administration levies on medical products during a hearing Tuesday.

FDA absent from Trump opioid panel

FDA absent from Trump opioid panel

By Steven Ross Johnson  |  April 01, 2017

Experts focused on finding ways to curb the number of overdoses in the U.S. say there's one very important person missing from President Donald Trump's commission—any representative from the federal agency regulating prescription drugs.

FDA warns of adverse events in patients with dissolving stent

By Adam Rubenfire  |  March 20, 2017

The Food and Drug Administration is warning physicians that patients implanted with the nation's only approved dissolvable heart stent may be having more cardiac issues than those with a traditional stent.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print